# Collaborative Care Diagnostics, LLC dba BioMedix – FDA Inspection, Feb 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/collaborative-care-diagnostics-llc-dba-biomedix/1ba8d970-64ae-4390-984d-9cc24ef4fe99
Source feed: FDA_Inspections

> FDA inspection 1302172 of Collaborative Care Diagnostics, LLC dba BioMedix, February 09, 2026. Classification: No Action Indicated (NAI). 4 citations under 21 CFR parts 801 and 830. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302172
- Company Name: Collaborative Care Diagnostics, LLC dba BioMedix
- Inspection Date: 2026-02-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Minneapolis District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1155197 - 2021-10-18](https://www.keypedia.com/records/fda_inspections/collaborative-care-diagnostics-llc-dba-biomedix/a1bdfbec-a722-4acd-b876-5dd8ae43d6da)
- [FDA Inspection 966212 - 2016-02-10](https://www.keypedia.com/records/fda_inspections/collaborative-care-diagnostics-llc-dba-biomedix/99f95507-f28b-4aee-a2c9-03e0c86cdf9e)
- [FDA Inspection 754147 - 2011-10-28](https://www.keypedia.com/records/fda_inspections/collaborative-care-diagnostics-llc-dba-biomedix/9b4cfab5-618f-411c-8289-3a2c1fa962e8)
- [FDA Inspection 579761 - 2009-05-05](https://www.keypedia.com/records/fda_inspections/collaborative-care-diagnostics-llc-dba-biomedix/c0ef4f77-4892-4375-a61e-20ade7224031)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/tyler-r-courtney/08ea96c4-cd5a-4793-b7e4-fb2b9ee2b9ef)

Company: https://www.keypedia.com/companies/collaborative-care-diagnostics-llc-dba-biomedix/70de2368-51b6-488d-a1a4-44deffe74cb3

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
